UBS O'Connor’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-92,441
Closed -$950K 660
2023
Q2
$950K Sell
92,441
-2,084
-2% -$21.3K 0.02% 385
2023
Q1
$959K Buy
+94,525
New +$951K 0.02% 411
2022
Q4
Sell
-95,450
Closed -$929K 547
2022
Q3
$929K Sell
95,450
-9,555
-9% -$92.9K 0.01% 758
2022
Q2
$1.02M Buy
+105,005
New +$1.02M 0.01% 762
2022
Q1
Sell
-103,154
Closed -$1M 402
2021
Q4
$1M Buy
+103,154
New +$1,000K 0.01% 656

Other funds holding HWEL

UBS O'Connor's HWEL Position: Q3 2023 in Review

UBS O'Connor sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q3 2023, closing a stake of 92,441 shares — an estimated $950K sold.

UBS O'Connor first reported a position in HWEL in Q4 2021 and held it in 5 quarters. The position peaked at $1.02M in Q2 2022. 11 funds tracked by Wall St. Rank hold HWEL as of Q3 2023.

  • UBS O'Connor reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 92,441 Healthwell Acquisition Corp. I Class A Common Stock shares in Q3 2023, an estimated $950K.
  • UBS O'Connor first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 5 quarters.
  • UBS O'Connor's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $1.02M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.